Lymphoepithelioma-like carcinoma and simultaneous marginal zone lymphoma of the skin: a case report von Gebauer, Niklas, Merz, Hartmut, Ottmann, Karl W, Tronnier, Michael

Volltext

Evapotranspiration estimation using a normalized difference vegetation index transformation of satellite data von SEEVERS, P. M., OTTMANN, R. W.

Volltext

Comparison of two analytical procedures for the determination of free urinary catecholamines under the demands of shiftwork experiments von RUTENFRANZ, J, OTTMANN, W, NEIDHART, B, BROCKMANN, W

Volltext

Subjective health status of day and shift-working policemen von OTTMANN, W., KARVONEN, M. J., SCHMIDT, K.-H., KNAUTH, P., RUTENFRANZ, J.

Volltext

Psychophysiological stress effects from the combination of night-shift work and noise: Psychophysiology of workload von BOUCSEIN, W, OTTMANN, W

Volltext

Psychophysiological stress effects from the combination of night-shift work and noise von Boucsein, Wolfram, Ottmann, Wolfgang

Volltext

Leisure time sport activities and maximal aerobic power during late adolescence von LANGE ANDERSEN, K, ILMARINEN, J, RUTENFRANZ, J, OTTMANN, W, BERNDT, I, KYLIAN, H, RUPPEL, M

Volltext

Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist von Lange Andersen, K, Piatkowski, W, Green, K A, Ottmann, W

Volltext

Working ability and exercise tolerance during treatment of mild hypertension. II: A comparison between atenolol and prazosin medication von ANDERSEN, K. L, OTTMANN, W, PIATKOWSKI, W, GREEN, K. A

Volltext

Analysis of 120 shift systems of the police in the Federal Republic of Germany von Knauth, P., Rutenfranz, J., Karvonen, M.J., Undeutsch, K., Klimmer, F., Ottmann, W.

Volltext

Working ability and exercise tolerance during treatment of a mild hypertension. I: Comparison between a beta-adrenoreceptor blocking drug and a calcium antagonist von ANDERSEN, K. L, PIATKOWSKI, W, GREEN, K. A, OTTMANN, W

Volltext

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia... von Pfeifer, H, Wassmann, B, Bethge, W, Dengler, J, Bornhäuser, M, Stadler, M, Beelen, D, Vucinic, V, Burmeister, T, Stelljes, M, Faul, C, Dreger, P, Kiani, A, Schäfer-Eckart, K, Schwerdtfeger, R, Lange, E, Kubuschok, B, Horst, H A, Gramatzki, M, Brück, P, Serve, H, Hoelzer, D, Gökbuget, N, Ottmann, O G

Volltext

Favourable levels of cardio-vascular health and risk indicators during childhood and adolescence von MACEK, M, RUTENFRANZ, J, OTTMAN, W, ANDERSEN, K. L, MASOPUST, J, VAVRA, J, KLIMMER, F, KYLIAN, H, DANEK, K, MACKOVA, J, FLORING, R

Volltext

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure von Hughes, Timothy P, Mauro, Michael J, Cortes, Jorge E, Minami, Hironobu, Rea, Delphine, DeAngelo, Daniel J, Breccia, Massimo, Goh, Yeow-Tee, Talpaz, Moshe, Hochhaus, Andreas, le Coutre, Philipp, Ottmann, Oliver, Heinrich, Michael C, Steegmann, Juan L, Deininger, Michael W.N, Janssen, Jeroen J.W.M, Mahon, Francois-Xavier, Minami, Yosuke, Yeung, David, Ross, David M, Tallman, Martin S, Park, Jae H, Druker, Brian J, Hynds, David, Duan, Yuyan, Meille, Christophe, Hourcade-Potelleret, Florence, Vanasse, K. Gary, Lang, Fabian, Kim, Dong-Wook

Volltext

Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study von Giles, F J, le Coutre, P D, Pinilla-Ibarz, J, Larson, R A, Gattermann, N, Ottmann, O G, Hochhaus, A, Radich, J P, Saglio, G, Hughes, T P, Martinelli, G, Kim, D-W, Novick, S, Gillis, K, Fan, X, Cortes, J, Baccarani, M, Kantarjian, H M

Volltext

Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies von DeAngelo, D J, Spencer, A, Bhalla, K N, Prince, H M, Fischer, T, Kindler, T, Giles, F J, Scott, J W, Parker, K, Liu, A, Woo, M, Atadja, P, Mishra, K K, Ottmann, O G

Volltext

Macrocycle-stabilization of its interaction with 14-3-3 increases plasma membrane localization and activity of CFTR von Stevers, Loes M., Wolter, Madita, Carlile, Graeme W., Macdonald, Dwight, Richard, Luc, Gielkens, Frank, Hanrahan, John W., Thomas, David Y., Chakka, Sai Kumar, Peterson, Mark L., Thomas, Helmut, Brunsveld, Luc, Ottmann, Christian

Volltext

Bim and Bad Mediate Imatinib-Induced Killing of Bcr/Abl⁺ Leukemic Cells, and Resistance Due to Their Loss Is Overcome by a BH3 Mimetic von Kuroda, Junya, Puthalakath, Hamsa, Cragg, Mark S., Kelly, Priscilla N., Bouillet, Philippe, Huang, David C. S., Kimura, Shinya, Ottmann, Oliver G., Druker, Brian J., Villunger, Andreas, Roberts, Andrew W., Strasser, Andreas

Volltext

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias von Ottmann, Oliver G., Druker, Brian J., Sawyers, Charles L., Goldman, John M., Reiffers, Jose, Silver, Richard T., Tura, Sante, Fischer, Thomas, Deininger, Michael W., Schiffer, Charles A., Baccarani, Michele, Gratwohl, Alois, Hochhaus, Andreas, Hoelzer, Dieter, Fernandes-Reese, Sofia, Gathmann, Insa, Capdeville, Renaud, O'Brien, Stephen G.

Volltext

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease von Fiedler, Walter, Serve, Hubert, Döhner, Hartmut, Schwittay, Michael, Ottmann, Oliver G., O'Farrell, Anne-Marie, Bello, Carlo L., Allred, Randy, Manning, William C., Cherrington, Julie M., Louie, Sharianne G., Hong, Weiru, Brega, Nicoletta M., Massimini, Giorgio, Scigalla, Paul, Berdel, Wolfgang E., Hossfeld, Dieter K.

Volltext